Abstract

Since the beginning of time, when man learned what he could do with his penis, Peyronie’s disease (PD) has haunted him. Surgical treatment had been the mainstay, but in the past few years, a less invasive option has taken front stage. We present the preliminary treatment data from one Urologist, fellowship trained in Sexual Medicine during the era of Xiaflex. This data provides a preliminary review of Xiaflex therapy for the treatment of PD for one provider at one REMS certified site. Over 40 patients had Xiaflex ordered for them in a 2 year period, at one REMS certified site. Penile dopplers with intracavernosal injections where utilized for accurate measurement of curvature. The treatment protocol was followed, as described in the initial FDA approved trial, including the appropriate exclusion criteria. Curve was measured at the beginning of each cycle. No more than 4 cycles were performed for each individual curve.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.